로딩 중…
지수 로딩 중…
Boryung Corporation
003850· KOSPI· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩9,090-0.98%
2026-06-19
Price Chart
Boryung Corporation+9.78%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 779.81B KRW |
| Revenue | 1.03T KRW |
| Net Income | 105.39B KRW |
| Total Assets | 1.40T KRW |
| Net Assets | 873.71B KRW |
| Employees | 1,646 |
| Value | |
| P/E | 7.40x |
| P/B | 0.89x |
| PEG | 0.00x |
| P/S | 0.76x |
| EV/EBITDA | 9.73x |
| FCF Yield | 8.93% |
| Profitability | |
| ROE | 12.06% |
| ROA | 7.52% |
| Op. Margin | 7.20% |
| Revenue Growth | 6.15% |
| Earnings Growth | 11762.37% |
| Financial Health | |
| Debt Ratio | 60.46% |
| Total Debt | 199.61B KRW |
| FCF | 69.64B KRW |
| Cash | 256.18B KRW |
| Current Ratio | 2.61x |
| Net Debt/EBITDA | -0.76x |
| Dividend | |
| Div. Yield | 1.74% |
| Div. Growth | 60.00% |
| Performance | |
| 1Y Return | 9.78% |
| 1M Return | -1.73% |
| From 52W High | -15.83% |
| 1Y MDD | -25.84% |
| Trading | |
| Volume | 155,628 shares |
| Foreign Own. | 6.47% |
| Per Share | |
| EPS | 1,229 KRW |
| BPS | 10,342 KRW |
Company Info
Boryung, established in 1963 and listed on the securities market in 1988, operates in pharmaceutical manufacturing and sales. The company is expanding its market share in chronic metabolic diseases and oncology with its new drug Kanarb in the professional pharmaceutical sector, achieving results across diverse business divisions. Boryung strives to become a leading healthcare company with high profitability and stable cash generation by maximizing proprietary product capabilities and expanding essential medicine manufacturing infrastructure. Boryung is headquartered in Jongno-gu, Seoul.